StockNews.AISignal intelligence
Company intelligence

TEM

Tempus AI, Inc. · NASDAQ · Healthcare

Price$76.05+7.98% · +$5.62
Market cap13.49BEquity value
P / E-152.1Trailing ratio
Volume6.27MLatest session
Market data

TEM price chart

TradingView
Related signals
1 min delayed

Browse public TEM signals with their source context and measured market impact. Open any signal for its permanent analysis page.

TEMNov 2, 2026-5.04% since signal

Tempus AI Posts Solid Q3, Expands Data Deals with BMY and Pathos

Tempus AI reported a solid Q3 with adjusted EPS of $0.07 and revenue of $411.5 million, surpassing estimates. The company highlighted 32% oncology revenue growth and robust Data & Applications momentum, plus multi-year collaborations with Bristol Myers Squibb and Pathos that add up to $192.5 million in future data revenue. The stock rose about 10% on the news, pointing to a data-driven growth path with meaningful longer-term revenue visibility.

View signal analysis
TEMJul 30, 2026-0.95% since signal

Tempus AI Q2 Beat; guidance raised, but growth pace under scrutiny

Tempus AI posted Q2 revenue of $382.5M, up 22% YoY and above estimates, with Diagnostics at $289.3M and Data & Applications at $93.2M. The company raised full-year revenue guidance to about $1.595–$1.605B and targets roughly $65M in adjusted EBITDA, excluding the planned Personalis acquisition. After-hours shares fell as investors weighed near-term growth against the long-term AI-driven opportunity.

View signal analysis
Research

Company intelligence